Jefferies on TCS
Target Price: Rs. 3,100 | Rating: Hold
Data center foray to diversify revenues, but expected contribution only ~3% in 5 years.
Morgan Stanley on Dabur
Target Price: Rs. 400 | Maintain Underweight
H2 revenues to grow mid-to-high single digits led by low base and winter product demand.
Morgan Stanley on Canara Bank
Target Price: Rs. 115 | Maintain Underweight
NII beat aided by IT refund; underlying profitability remains under pressure.
Morgan Stanley on Cipla
Target Price: Rs. 1,396 | Maintain Underweight
Muted EPS growth; near-term slowdown seen until H2.
Morgan Stanley on NTPC
Target Price: Rs. 409 | Maintain Overweight
FY26 commissioning guidance lowered to 9.8 GW versus earlier 11.8 GW.
MOSL on Swiggy
Target Price: Rs. 551 | Recommendation: Buy
Capex moderation aids margins; competitive intensity remains key risk.
UBS on Swiggy
Target Price: Rs. 580 | Maintain Buy
Q2 trends solid across segments; QIP to ease balance sheet concerns.
Citi on Dabur
Target Price: Rs. 475 | Recommendation: Sell
Growth challenges persist; sustained improvement in profitability crucial.
Citi on Hyundai
Target Price: Rs. 2,900 (Maintain Buy)
Festive retail demand strong; exports likely to beat guidance.
Citi on ITC
Target Price: Rs. 500 (Maintain Buy)
Cigarettes up 7% YoY; FY27 margin recovery expected.
Nuvama on Nippon Life AMC
Target Price: Rs. 1,090 | Maintain Buy
Core earnings growth strong; valuation rolled to Sep-27E.
Goldman Sachs on Hyundai
Target Price: Rs. 2,970 | Maintain Buy
Festive retail up 23% YoY; exports growth expected to exceed targets.
Nuvama on United Breweries
Target Price: Rs. 2,270 | Maintain Buy
Short-term disruption due to floods; strong recovery expected ahead.
Macquarie on Swiggy
Target Price: Rs. 285
Growth continues; platform EBITDA losses remain high.
Morgan Stanley on Swiggy
Target Price: Rs. 450 | Maintain Overweight
EBITDA loss better than estimates; steady-state margin target at 5%.
Goldman Sachs on Dabur
Target Price: Rs. 500 | Maintain Neutral
Revenue up 5.4% YoY; management guides mid-to-high single-digit growth for H2.
Goldman Sachs on Cipla
Target Price: Rs. 1,425 | Maintain Sell
Revenue up 8% YoY; EPS cut 1–4% for FY26–28 on slower US growth.
Leave A Comment